Company Description
Time may eventually heal all wounds, but in the meantime there's Derma Sciences. The company has three product lines: sprays, ointments, and...
Key Derma Sciences Financials
| Company Type | Public - OTC: DSCI Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $34.1 |
| Employees | -- |
More Derma Sciences Financials (8 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Derma Sciences's competition across multiple industries
Top Derma Sciences Competitors
Sponsored Links
The Business Directory
Derma Sciences Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Edward J. Quilty | Network | E-mail |
| EVP Sales | Robert C. Cole | Network | E-mail |
| VP and CFO | John E. Yetter | Network | E-mail |
More Derma Sciences Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Derma Sciences News
- DSCI: CEO Discusses Q1 Results and Plans to Increase Revenues and Profits [Knobias.com] (15 May 2008 15:53:00 EDT)
- DSCI: Q1 Earnings Call @ 11:00 ET Today [delayed] [Knobias.com] (15 May 2008 08:20:00 EDT)
- DJ Companies Notifying SEC of Late Reports -2- [OsterDowJones] (14 May 2008 18:21:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.